Back
HFA Premium Access

Sacubitril/Valsartan and SGLT2i: a safe combination?

Session: Poster Session 1 - Pharmacology and Pharmacotherapy
Topic: Cardiovascular Pharmacotherapy, Other
Speaker: Doctor C. Goena Vives (Donostia, ES)
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Cristina Goena Vives

Donostia University Hospital, Donostia (Spain)
3 presentations
0 follower

10 more presentations in this session

Sacubitril valsartan in real life: tolerance, clinical evolution and remodeled long term

Speaker: Doctor R. Bravo-Marques (Marbella, ES)

Access
Abstract
Like
Thumbnail

Security of neurohormonal blocking with sacubitril / valsartan, iSGLT2 and mineralocorticoid receptor antagonist in patients with heart failure with reduced eyection fraction and diabetes mellitus

Speaker: Doctor R. Bravo-Marques (Marbella, ES)

Access
Abstract
Like
Thumbnail

Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment

Speaker: Doctor C. Goena Vives (Donostia, ES)

Access
Abstract
Slides
Like
Thumbnail

Long-term prognostic impact of beta-blocker prescription during hospitalization for acute myocardial infarction

Speaker: Doctor F. Fonseca Goncalves (Vila Real, PT)

Access
Abstract
Slides
Like
Thumbnail

Diabetic patients need higher loop diuretic doses: a report on acute and chronic heart failure patients

Speaker: Associate Professor P. Bettencourt (Porto, PT)

Access
Like
Thumbnail

Access the full session

Poster Session 1 - Pharmacology and Pharmacotherapy

Speakers: Doctor C. Goena Vives, Doctor R. Bravo-Marques, Doctor R. Bravo-Marques, Doctor C. Goena Vives, Doctor F. Fonseca Goncalves...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources